Accelerating Adoption of Patient-centered Cervical Cancer Screening and Treatment Linkage in Kenya

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexFemale
Age25-49
SponsorKenyatta National Hospital

About this trial

This study aims to test the use of a multi-component care strategy (DADA LINK) designed to improve cervical cancer screening and linkage to treatment. The duration of the trial is 12 months, with a 6-month follow-up period to evaluate intervention costs and measure maintenance of the care strategies. Study staff at each clinic will abstract data on cervical cancer screening and triage/treatment. Clinics randomized to the intervention arm will have care coordinators who motivate clinic staff to adhere to cervical cancer care guidelines, conduct patient exit surveys to assess intervention fidelity, and support care coordination through use of the mHealth platform (WEMA).

Eligibility criteria

Qualifiers

None

Disqualifiers

Pregnant women

Women ≤6 weeks postpartum

Women already confirmed to have cervical cancer

Trial design

Treatments tested in this trial

  • DADA LINK

Treatment groups

1,980 Participants
are divided into 2 treatment groups

Sponsors and collaborators

Kenyatta National Hospital

Lead sponsor

Emory University

Collaborator

University of Washington

Collaborator

National Cancer Institute (NCI)

Collaborator

Kenya Ministry of Health

Collaborator

Queen's University

Collaborator

University of Nairobi

Collaborator